Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zuid-Oost Nederland Protonen Therapie Centrum (ZONPTC), operating as Maastro Proton Therapy, is a specialized oncology facility located in Maastricht, Netherlands. Established as a joint venture between Maastro Clinic and Maastricht UMC+, the center provides advanced proton beam therapy to patients with a variety of solid tumors. This modality allows for high-precision radiation delivery, significantly sparing healthy surrounding tissue compared to conventional photon therapy. The facility is equipped with the Mevion S250i Hyperscan system, featuring Adaptive Aperture technology for optimized beam shaping. ZONPTC serves as a critical regional hub for cancer treatment, clinical trials, and technical innovation in particle therapy. By focusing on indications such as head and neck, lung, and brain cancers, the center aims to improve patient outcomes and reduce treatment-related complications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zuid-Oost Nederland Protonen Therapie Centrum.